All In MedTech

Device Trial Radar · NCT07793604

Increasing Mitochondrial Respiration as a Novel Mechanism for Cognitive Augmentation

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Oct 1, 2026

Primary completion

Dec 2029

Study completion May 2030

Sponsor

Lead sponsor
Francisco Gonzalez-Lima, PhDAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the effects of increasing brain energy on cognition. The hypothesis is that by using a special kind of light, in combination with a nutritional supplement, it may be possible to increase energy production in the brain, which may lead to improvements in cognition.

Conditions

  • Cognition Improvement
  • Emotion Regulation

Interventions

  • Active transcranial photobiomodulationDevice

    Infrared light delivered to the forehead, administered with a headset using light-emitting diodes (LEDs)

  • Active MCT dietary supplementationDietary supplement

    Commercially-available food-grade refined coconut oil for ketogenic dietary supplementation

  • Sham photobiomodulationDevice

    Identical procedure as active group, but with 5% of light emitted by the device.

  • Sham dietary supplementationDietary supplement

    Identical appearance and administration as active dietary supplementation, but with commercially-available food-grade sunflower oil (comparable caloric value without ketone production).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cognitive assessment: Montreal Cognitive Assessment (MoCA)Time frame: The MoCA will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)
  2. Cognitive assessment: Trail-Making TestTime frame: The TMT will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)
  3. Brain metabolism assessment: Functional Near-Infrared Spectroscopy (fNIRS)Time frame: The fNIRS procedure will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The University of Texas at Austin

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.